1100702
The Brigham and Women's Hospital, Inc. — FEI 3012030543
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- August 22, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Boston, MA (United States)
Citations
| ID | CFR | Description |
| 17759 | 21 CFR 212.20(c) | Adverse effects of changes made |
| 17763 | 21 CFR 212.20(d) | Determination need for investigation |
| 17764 | 21 CFR 212.20(e) | Written QA procedures established, followed |
| 17851 | 21 CFR 212.60(c) | Analytical methods |
| 21376 | 21 CFR 212.30(a) | Orderly handling, prevention of mix-ups, prevention of contamination |